MORGAN STANLEY - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$72,000
-12.2%
182,084
+23.5%
0.00%
Q2 2022$82,000
-49.1%
147,385
+2.3%
0.00%
Q1 2022$161,000
-36.4%
144,139
-16.8%
0.00%
Q4 2021$253,000
-83.1%
173,312
-65.3%
0.00%
Q3 2021$1,499,000
-64.7%
499,497
-45.4%
0.00%
-100.0%
Q2 2021$4,244,000
+321.4%
914,566
+445.2%
0.00%
Q1 2021$1,007,000
-51.5%
167,741
-57.7%
0.00%
Q4 2020$2,078,000
+437.0%
396,654
+255.0%
0.00%
Q3 2020$387,000
-74.8%
111,742
-36.7%
0.00%
Q2 2020$1,533,000
+336.8%
176,604
+192.2%
0.00%
Q1 2020$351,000
-77.9%
60,439
-72.6%
0.00%
Q4 2019$1,588,000
+249.0%
220,373
+195.0%
0.00%
Q3 2019$455,000
-57.5%
74,707
-33.7%
0.00%
Q2 2019$1,070,000
-70.6%
112,621
-74.9%
0.00%
-100.0%
Q1 2019$3,644,000
+192.0%
449,275
+485.5%
0.00%
Q4 2018$1,248,000
-38.5%
76,729
-38.4%
0.00%
-100.0%
Q3 2018$2,028,000
+201.8%
124,478
+178.8%
0.00%
Q2 2018$672,00044,6420.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$7,294,0008.07%
Invus Financial Advisors, LLC 1,094,998$5,081,0001.01%
Founders Fund V Management, LLC 491,751$2,282,0000.78%
Tibra Equities Europe Ltd 80,700$374,0000.12%
GSA CAPITAL PARTNERS LLP 205,882$955,0000.11%
Hall Private Wealth Advisors 18,500$86,0000.06%
20/20 Capital Management, Inc. 42,840$199,0000.05%
OCCUDO QUANTITATIVE STRATEGIES LP 64,789$301,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 759,918$3,526,0000.02%
PDT Partners, LLC 74,178$344,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders